KK
Kelly A. Kramer (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $713K of GILD (5,611 sh across 2 lots, as filed), executed Nov 26 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$713K
shares × price, as filed
Last traded
Nov 28 2025
Filed Dec 1 2025
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $713K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$713K5,611 sh across 2 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET